Lumbar Degenerative Disc Disease Market by Treatment, Route of Administration, End-Users - Global Forecast 2025-2030- Product Image

Sale

Lumbar Degenerative Disc Disease Market by Treatment, Route of Administration, End-Users - Global Forecast 2025-2030

Report
184 Pages
October 2024
Region: Global
360iResearch™
ID: 5944537

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Lumbar Degenerative Disc Disease Market grew from USD 744.58 million in 2023 to USD 796.33 million in 2024. It is expected to continue growing at a CAGR of 7.15%, reaching USD 1.20 billion by 2030.

Lumbar Degenerative Disc Disease (DDD) encompasses conditions affecting the intervertebral discs in the lower back, leading to pain, reduced flexibility, and potential neurological symptoms. Addressing it involves a wide range of non-invasive therapies, surgical interventions, and emerging regenerative treatments. The necessity for effective solutions arises from the increasing prevalence of DDD among the aging population, compounded by rising incidences of obesity and sedentary lifestyles. The application scope spans pharmaceuticals, biologicals like stem cell therapy, physiotherapy, and minimally invasive surgeries, with end-users ranging from hospitals and specialty clinics to research institutions. Markets for lumbar DDD solutions are influenced by technological advancements, patient awareness, and insurance coverage improvements. A significant growth factor is the increasing preference for minimally invasive and regenerative techniques, backed by supportive regulatory frameworks. Latest opportunities lie in developing biologics and enhancing imaging technologies to improve diagnostic accuracy and treatment outcomes. However, market growth faces challenges such as high treatment costs, regulatory hurdles, and a lack of skilled professionals in cutting-edge therapies. Moreover, limited patient awareness in developing regions acts as a bottleneck. Innovation areas ripe for exploration include gene therapy, advanced biomaterials for disc replacement, AI-driven diagnostic tools, and personalized medicine approaches to tailor treatments. These innovations can revolutionize treatment efficacy and patient outcomes. The market is characterized by intense R&D activity, strategic collaborations, and mergers and acquisitions aimed at expanding product portfolios and geographical presence. Despite challenges, sustained focus on R&D, patient education, and strategic partnerships can unlock significant opportunities in this dynamic market. Companies that can effectively navigate regulatory landscapes and integrate innovations are well-positioned to lead the market.

Understanding Market Dynamics in the Lumbar Degenerative Disc Disease Market

The Lumbar Degenerative Disc Disease Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of lumbar degenerative disc disease
- Rising awareness campaigns and education about LDDD
Market Restraints
- Limited availability of reimbursement
Market Opportunities
- Ongoing R&D for introducing new LDDD treatments and diagnosis
- Favorable government approvals for LDDD medicine commercialization
Market Challenges
- Complexity in surgical procedures and medicine development

Exploring Porter’s Five Forces for the Lumbar Degenerative Disc Disease Market

Porter’s Five Forces framework further strengthens the insights of the Lumbar Degenerative Disc Disease Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Lumbar Degenerative Disc Disease Market

External macro-environmental factors deeply influence the performance of the Lumbar Degenerative Disc Disease Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Lumbar Degenerative Disc Disease Market

The Lumbar Degenerative Disc Disease Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Lumbar Degenerative Disc Disease Market

The Lumbar Degenerative Disc Disease Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Lumbar Degenerative Disc Disease Market

The Lumbar Degenerative Disc Disease Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lumbar Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AnGes MG, Inc., AxioMed LLC, B. Braun SE, Baxter International Inc., Benvenue Medical, Inc., Biopharm GmbH, Boston Scientific Corporation, Centinel Spine, LLC, Cerapedics Inc., ChoiceSpine, DePuy Synthes by Medical Device Business Services, Inc., Globus Medical, Inc., Kolon TissueGene Inc., Kuros Biosciences, Lineage Cell Therapeutics, Inc., Medtronic plc, NLC Ventures Netherlands B.V., Notogen, Inc., Orthofix Medical Inc., RTI Surgical Holdings, Inc., Stryker Corporation, Ulrich Medical USA Inc., Veritas Health, LLC, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Lumbar Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment
- Epidural Steroid Injections (ESIs)
- Over-the-counter (OTC) Pain Medications
  - Acetaminophen
  - Anti-inflammatories
  - Corticosteroids
  - Muscle Relaxants
  - Narcotics
- Therapy Devices
Route of Administration
- Injectables
- Oral
End-Users
- Academic Research Centers
- Hospitals & Clinics
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lumbar degenerative disc disease
5.1.1.2. Rising awareness campaigns and education about LDDD
5.1.2. Restraints
5.1.2.1. Limited availability of reimbursement
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for introducing new LDDD treatments and diagnosis
5.1.3.2. Favorable government approvals for LDDD medicine commercialization
5.1.4. Challenges
5.1.4.1. Complexity in surgical procedures and medicine development
5.2. Market Segmentation Analysis
5.2.1. Treatment: Rising usage of epidural steroid injections (ESIs) for management of lumbar degenerative disc disease
5.2.2. End-Users: Increasing need for lumbar degenerative disc disease treatment for diagnosing, treating, and managing patients
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Lumbar Degenerative Disc Disease Market, by Treatment

6.1. Introduction
6.2. Epidural Steroid Injections (ESIs)
6.3. Over-the-counter (OTC) Pain Medications
6.4. Therapy Devices

7. Lumbar Degenerative Disc Disease Market, by Route of Administration

7.1. Introduction
7.2. Injectables
7.3. Oral

8. Lumbar Degenerative Disc Disease Market, by End-Users

8.1. Introduction
8.2. Academic Research Centers
8.3. Hospitals & Clinics
8.4. Specialty Clinics

9. Americas Lumbar Degenerative Disc Disease Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Lumbar Degenerative Disc Disease Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Lumbar Degenerative Disc Disease Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Clears ReGelTec's HYDRAFIL System for Treatment of Lumbar Degenerative Disc Disease
12.3.2. RIT Researchers Awarded NIH Grant to CRISPR-Enhanced Stem Cell Therapy for Lumbar Degeneration
12.3.3. Companion Spine Advances Global Spine Health with Strategic Acquisition of Backbone SAS
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
FIGURE 2. LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LUMBAR DEGENERATIVE DISC DISEASE MARKET DYNAMICS
FIGURE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. LUMBAR DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. LUMBAR DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTIONS (ESIS), BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTIONS (ESIS), BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NARCOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NARCOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 67. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 68. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 69. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 70. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 71. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 72. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 73. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 74. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 75. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 76. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 77. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 78. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 79. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 80. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 81. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 82. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 111. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 112. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 113. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 114. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 115. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 116. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 117. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 118. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 119. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 120. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 121. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 122. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 123. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 124. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 125. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 126. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 135. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 136. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 137. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 138. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 139. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 140. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 141. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 142. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 183. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 184. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 185. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 186. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 187. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 188. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 189. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 190. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 209. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 210. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 211. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 212. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 213. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 214. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 215. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 216. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 217. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 218. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 219. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 220. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 221. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 222. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 223. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 224. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 225. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 226. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 227. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 228. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 229. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 230. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 231. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 232. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 233. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 234. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 235. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 236. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 237. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 238. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 239. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 240. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 241. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 242. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 243. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 244. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 245. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 246. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 247. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 248. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 257. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 258. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 259. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 260. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 261. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 262. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 263. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 264. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 281. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 282. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 283. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 284. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 285. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 286. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE

Companies Mentioned

The leading players in the Lumbar Degenerative Disc Disease market, which are profiled in this report, include:

Abbott Laboratories
AnGes MG, Inc.
AxioMed LLC
B. Braun SE
Baxter International Inc.
Benvenue Medical, Inc.
Biopharm GmbH
Boston Scientific Corporation
Centinel Spine, LLC
Cerapedics Inc.
ChoiceSpine
DePuy Synthes by Medical Device Business Services, Inc.
Globus Medical, Inc.
Kolon TissueGene Inc.
Kuros Biosciences
Lineage Cell Therapeutics, Inc.
Medtronic plc
NLC Ventures Netherlands B.V.
Notogen, Inc.
Orthofix Medical Inc.
RTI Surgical Holdings, Inc.
Stryker Corporation
Ulrich Medical USA Inc.
Veritas Health, LLC
Xtant Medical Holdings, Inc.
Zimmer Biomet Holdings, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 796.33 Million
Forecasted Market Value ( USD ) by 2030	$ 1200 Million
Compound Annual Growth Rate	7.1%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Lumbar Degenerative Disc Disease Market

Exploring Porter’s Five Forces for the Lumbar Degenerative Disc Disease Market

Applying PESTLE Analysis to the Lumbar Degenerative Disc Disease Market

Analyzing Market Share in the Lumbar Degenerative Disc Disease Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Lumbar Degenerative Disc Disease Market

Strategic Recommendations for Success in the Lumbar Degenerative Disc Disease Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Lumbar Degenerative Disc Disease (DDD) - Market Insight, Epidemiology and Market Forecast - 2034

Degenerative Disc Disease Market by Product Type, Treatment, End-Users - Global Forecast 2025-2030

Degenerative Disc Disease Treatment Market Report 2024

Degenerative Disc Disease Treatment Market By Drugs, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2023-2032

Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032